Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysisShow others and affiliations
2020 (English)In: Journal of Infectious Diseases, ISSN 0022-1899, E-ISSN 1537-6613, Vol. 221, no 7, p. 1107-1116Article in journal (Refereed) Published
Abstract [en]
OBJECTIVES: There are substantial variations in Neisseria gonorrhoeae susceptibility to antimicrobials between different populations, and the reasons for this are largely unexplored. We aimed to assess if the population level consumption of antimicrobials is a contributory factor.
METHODS: Using antimicrobial susceptibility data from 24 countries in the European Gonococcal Antimicrobial Surveillance Programme and antimicrobial consumption data from the IQVIA MIDAS database, we built mixed effects linear/logistic regression models with country-level cephalosporin, fluoroquinolone and macrolide consumption (standard doses/1000 population/year) as the explanatory variables (from 2009 to 2015) and 1-year lagged ceftriaxone, cefixime, azithromycin and ciprofloxacin geometric mean minimum inhibitory concentrations (MIC) as the outcome variables (2010 to 2016).
RESULTS: Positive correlations were found between the consumption of cephalosporins and geometric mean MIC of ceftriaxone and cefixime (both P's <0.05). Fluoroquinolone consumption was positively associated with the prevalence of resistance to ciprofloxacin (P<0.05).
CONCLUSIONS: Differences in population level consumption of particular antimicrobials may contribute to the variations in the level of antimicrobial resistance in N. gonorrhoeae in different settings. Further interventions to reduce misuse and overuse of antimicrobials in high-consumption populations and core-groups are required.
Place, publisher, year, edition, pages
Oxford University Press, 2020. Vol. 221, no 7, p. 1107-1116
Keywords [en]
Gonorrhea, antimicrobial resistance, antimicrobial consumption, ecological, Europe
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:oru:diva-73660DOI: 10.1093/infdis/jiz153ISI: 000559961100011PubMedID: 30957153Scopus ID: 2-s2.0-85082146608OAI: oai:DiVA.org:oru-73660DiVA, id: diva2:1304195
2019-04-112019-04-112020-12-01Bibliographically approved